AstraZeneca vaccine could boost US supply next month, but heighten skepticism
Surprisingly strong US clinical trial results reported by AstraZeneca on Monday raised the prospect of a fourth COVID-19 vaccine in the United States soon — and a potential supply surplus just as the general public becomes eligible for shots in Massachusetts ...
from Google Alert - Business https://ift.tt/3tYROCL
Surprisingly strong US clinical trial results reported by AstraZeneca on Monday raised the prospect of a fourth COVID-19 vaccine in the United States soon — and a potential supply surplus just as the general public becomes eligible for shots in Massachusetts ... https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/3tYROCL
Surprisingly strong US clinical trial results reported by AstraZeneca on Monday raised the prospect of a fourth COVID-19 vaccine in the United States soon — and a potential supply surplus just as the general public becomes eligible for shots in Massachusetts ... https://ift.tt/eA8V8J
Comments
Post a Comment